
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Undisclosed
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Preclinical
Sponsor : Bill & Melinda Gates Foundation
Deal Size : $6.6 million
Deal Type : Funding
Attivare Therapeutics Receives $6.6M Grant for Malaria Vaccine
Details : The funding will support the development of a new vaccine targeting malaria.
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Undisclosed
December 15, 2025
Lead Product(s) : Undisclosed
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Preclinical
Sponsor : Bill & Melinda Gates Foundation
Deal Size : $6.6 million
Deal Type : Funding
